US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority shareholding in New Zealand Clinical Research Group (NZCR Group), a leading clinical trials and medical research organisation in New Zealand and Australia. NZCR Group’s clinician shareholders and management, along with local private equity investor Waterman Capital, are retaining a significant minority shareholding, reflecting their ongoing confidence in the business and commitment to its future. This also ensures continuity for customers, employees, and other stakeholders. NZCR Group is a leading physician-led clinical research organisation with more than 35 years of research experience and a strong track record in complex early and later-phase studies.
Read the full article: Advent Acquires Majority Stake in New Zealand Clinical Research Group //
Source: https://www.biospectrumasia.com/news/47/28259/advent-acquires-majority-stake-in-new-zealand-clinical-research-group.html